Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Comparison of monotherapy and combination therapy for older patients with advanced biliary tract cancer: a retrospective study

Fig. 2

Progression-free survival stratified by treatment group. Kaplan–Meier curves for overall survival in the combination therapy group versus the monotherapy group. The median progression-free survival in the combination therapy and monotherapy groups was 9.2 (95% CI, 6.7–11.3) and 5.7 (95% CI, 4.9–8.6) months, respectively. CI, confidence interval; HR, hazard ratio

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us